Research and Development

GlaxoSmithKline chief executive Andrew Witty has been appointed president of EFPIA.He previously served as vice-president of the European industry association for two years and takes …

The market for contract services in the pharmaceutical sector has been pegged back since the end of 2008, but looks …

Roche has unveiled plans for its new main office building in Basel, Switzerland, that will accommodate more than 1,800 people …

Serge Weinberg has joined the board of directors at Sanofi-Aventis, replacing Gunter Thielen, who has resigned for personal reasons. The …

Cancer Research UK and Cancer Research Technology (CRT), the charity’s development and commercialisation arm, are to undertake a phase I …

Founded in 1986, Celgene was created as a spin off from the Celanese Corporation. Two years later, the company received …

This year saw two ‘mega mergers’ in the sector, the acquisition of Wyeth by Pfizer and the reverse takeover of …

Our round-up of developments in the contract research sector includes updates from ICON, SynRG, AAIPharma, Covance, Benten BioServices, Phase Forward …

Sanofi-Aventis has received the backing of a key European regulatory committee for its cardiology treatment DuoPlavin, which combines its blockbuster …

Merck & Co. appoints Dr Michael Rosenblatt executive VP and chief medical officer. He will be the company’s primary voice …

Merck & Co has bolstered its capabilities in biologics production with the acquisition of contract manufacturer Avecia Biologics. The deal …

Dr Nawab Qizilbash, MBChB BSc MRCP (UK) MSc Phil (Oxon) is the Director of OXON Epidemiology Ltd. He served as …

Boehringer Ingelheim has started a new phase III trial for its investigational cancer drug BIBF 1120. The LUME-Ovar-1 programme will …

A new online resource has been launched to help stem cell researchers in the UK plan a regulatory route for …

Irish contract research organisation ICON has provided additional details on its new translational medicine unit in Manchester, UK, first announced …